Through multi-omics integration, we have constructed for the first time a causal pathway linking mitochondrial-related genes, metabolic pathways, and cholelithiasis, providing theoretical support for personalized therapies targeting the genes LIAS, TARS2, HEBP1, and PNKD. The gene discussed is LIAS; the disease is cholelithiasis.